HLA-B was proven to be a member of the NF-kappaB module NFKB_IRFF_01, which, was activated in the inflammatory stress response of progressive DN and could be a potential target for the treatment of progressive renal diseases such as DN [41]. The gene discussed is NFKB1; the disease is liver dysplastic nodule.